SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-15-031984
Filing Date
2015-04-30
Accepted
2015-04-30 08:04:44
Documents
9
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A a15-1494_3defa14a.htm DEFA14A 53769
2 GRAPHIC g14943bgi001.jpg GRAPHIC 84839
3 GRAPHIC g14943bgi002.jpg GRAPHIC 153151
4 GRAPHIC g14943bgi003.jpg GRAPHIC 78454
5 GRAPHIC g14943bgi004.jpg GRAPHIC 20254
6 GRAPHIC g14943bci001.gif GRAPHIC 3932
7 GRAPHIC g14943bci002.jpg GRAPHIC 24809
8 GRAPHIC g14943bci003.jpg GRAPHIC 3076
9 GRAPHIC g14943bii001.jpg GRAPHIC 84731
  Complete submission text file 0001104659-15-031984.txt   680435
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32966 | Film No.: 15815317
SIC: 2836 Biological Products, (No Diagnostic Substances)